What amount sold does ICP Phoenix Investors, LLC report in Form D filings?

The latest linked filings report $5M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was ICP Phoenix Investors, LLC's most recent SEC filing?

ICP Phoenix Investors, LLC's most recent Form D filing was on 2025-04-22.

How many investors does ICP Phoenix Investors, LLC have?

The most recent Form D filing lists 1 investor(s).

ICP Phoenix Investors, LLC

CIK: 0002064428·Pooled Investment Fund·TYSONS, VA·Limited Liability Company

Reported Sold

$5,000,200

Total Filings

Identified Offerings

Last Filed

Apr 22, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pooled Investment Fund industry

SEC EDGAR

Offering filing timeline

Apr 22, 2025Form D — New notice

Reported sold: $5,000,200 · Target: $5,000,200

Rule 506(b)·1 investor·Section 3(c), Section 3(c)(7)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$5,000,200

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Michael Raue

Related Person

Appears on 1 filing

Clarendon Capital, LLC

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Apr 22, 2025	New	$5,000,200	$5,000,200	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

HG Israel Holdings II, LLC

Pooled Investment Fund

Offering target: $3,753,405

Filed Oct 26, 2026